Kidswell Bio Corporation announced a private placement to issue 150,000 common shares at ¥152 per share for gross proceeds of ¥22,800,000 on July 10, 2023. The transaction included the participation from returning investor CVI Investments for 19,518,922 shares and owned by 37.85% stake. The company issued shares through third party allotment method.

The transaction is expected to close on July 26, 2023.